Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: a paradigm for treatment individualization.
作者信息
White Julia, Mamounas Eleftherios
机构信息
The Ohio State University Comprehensive Cancer Center, Columbus, OH.
出版信息
J Clin Oncol. 2014 Feb 20;32(6):494-5. doi: 10.1200/JCO.2013.53.4974. Epub 2013 Dec 30.
Abstract
摘要
相似文献
1
Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: a paradigm for treatment individualization.新辅助化疗有反应的乳腺癌患者的局部区域放疗：治疗个体化的范例
J Clin Oncol. 2014 Feb 20;32(6):494-5. doi: 10.1200/JCO.2013.53.4974. Epub 2013 Dec 30.
2
3
The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer.日本乳腺癌学会乳腺癌放射治疗临床实践指南
Breast Cancer. 2015 Jan;22(1):49-58. doi: 10.1007/s12282-014-0548-9. Epub 2014 Jul 15.
4
Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review.基于新辅助化疗后治疗反应的乳腺癌术后放疗和区域淋巴结放疗个体化：系统评价。
Strahlenther Onkol. 2018 Jul;194(7):607-618. doi: 10.1007/s00066-018-1270-x. Epub 2018 Jan 30.
5
[Neoadjuvant systemic therapy in breast cancer].[乳腺癌的新辅助全身治疗]
Orv Hetil. 2009 Jan 11;150(2):65-71. doi: 10.1556/OH.2009.28536.
6
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.新辅助化疗后局部区域复发的预测因素：国家外科辅助乳腺和肠道项目 B-18 和 B-27 联合分析的结果。
J Clin Oncol. 2012 Nov 10;30(32):3960-6. doi: 10.1200/JCO.2011.40.8369. Epub 2012 Oct 1.
7
Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.新辅助化疗及局部区域治疗后临床诊断为多灶性或多中心性乳腺癌的局部区域控制
J Clin Oncol. 2006 Nov 1;24(31):4971-5. doi: 10.1200/JCO.2006.07.6067.
8
Radiotherapy Issues After Neoadjuvant Chemotherapy.新辅助化疗后的放疗问题
J Natl Cancer Inst Monogr. 2015 May;2015(51):87-9. doi: 10.1093/jncimonographs/lgv003.
9
Evaluating neoadjuvant chemotherapy in breast cancer.评估乳腺癌新辅助化疗
J Clin Oncol. 2002 Jun 15;20(12):2905-6; author reply 2906-7. doi: 10.1200/JCO.2002.20.12.2905.
10
Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.诊断时伴有同侧锁骨上转移的乳腺癌患者的局部区域治疗结果。
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):490-6. doi: 10.1016/j.ijrobp.2006.08.040.
引用本文的文献
1
The effect of postmastectomy radiotherapy after neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis.新辅助化疗后乳腺癌患者乳房切除术后放疗的效果：一项荟萃分析。
Future Oncol. 2025 Jun;21(15):1929-1938. doi: 10.1080/14796694.2025.2505372. Epub 2025 Jun 2.
2
Does Post-Mastectomy Radiotherapy Confer Survival Benefits on Patients With 1-3 Clinically Positive Lymph Nodes Rendered Pathologically Negative After Neoadjuvant Systemic Chemotherapy: Consensus from A Pooled Analysis?新辅助全身化疗后病理转为阴性的1-3个临床阳性淋巴结的患者，乳房切除术后放疗是否能带来生存获益：一项汇总分析的共识？
Eur J Breast Health. 2024 Apr 1;20(2):81-88. doi: 10.4274/ejbh.galenos.2024.2023-12-14. eCollection 2024 Apr.
3
Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis.新辅助化疗后达到病理完全缓解的乳腺癌患者的辅助性局部区域放射治疗：一项系统评价和荟萃分析。
Clin Transl Radiat Oncol. 2022 Jan 5;33:45-52. doi: 10.1016/j.ctro.2021.12.010. eCollection 2022 Mar.
4
Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation.TRIB3通过调节Notch1激活参与三阴性乳腺癌细胞的辐射反应
Cancers (Basel). 2019 Jan 22;11(2):127. doi: 10.3390/cancers11020127.
5
Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review.基于新辅助化疗后治疗反应的乳腺癌术后放疗和区域淋巴结放疗个体化：系统评价。
Strahlenther Onkol. 2018 Jul;194(7):607-618. doi: 10.1007/s00066-018-1270-x. Epub 2018 Jan 30.
6
Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.新辅助化疗和手术之后，对临床II期和III期联合乳腺癌单独进行局部放疗。
Radiat Oncol. 2016 Jul 26;11:93. doi: 10.1186/s13014-016-0670-2.
7
Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available data.新辅助化疗后乳房切除术后放射治疗：现有数据的综述与解读
Ther Adv Med Oncol. 2016 Jan;8(1):85-97. doi: 10.1177/1758834015617459.
8
The position and current status of radiation therapy after primary systemic therapy in breast cancer: a national survey-based expert consensus statement.乳腺癌初次全身治疗后放射治疗的位置及现状：一项基于全国调查的专家共识声明
Clin Transl Oncol. 2016 Jun;18(6):582-91. doi: 10.1007/s12094-015-1401-0. Epub 2015 Sep 14.
9
Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy.新辅助化疗、手术和放疗后三阴性乳腺癌的局部区域复发率较高。
Springerplus. 2015 Jul 30;4:386. doi: 10.1186/s40064-015-1116-2. eCollection 2015.
10
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).早期乳腺癌管理中原发性全身治疗的国际专家共识：可手术乳腺癌管理中原发性全身治疗第五届研讨会要点，意大利克雷莫纳（2013年）
J Natl Cancer Inst Monogr. 2015 May;2015(51):90-6. doi: 10.1093/jncimonographs/lgv023.
本文引用的文献
1
Reducing local therapy in patients responding to preoperative systemic therapy: are we outsmarting ourselves?减少对术前全身治疗有反应的患者的局部治疗：我们是不是弄巧成拙了？
J Clin Oncol. 2014 Feb 20;32(6):491-3. doi: 10.1200/JCO.2013.51.3523. Epub 2013 Dec 30.
2
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.新辅助化疗后局部区域复发的预测因素：国家外科辅助乳腺和肠道项目 B-18 和 B-27 联合分析的结果。
J Clin Oncol. 2012 Nov 10;30(32):3960-6. doi: 10.1200/JCO.2011.40.8369. Epub 2012 Oct 1.
3
Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer.新辅助化疗后 II-III 期乳腺癌术后放疗的作用。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):494-503. doi: 10.1016/j.ijrobp.2012.01.068.
4
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.保乳手术后放疗对 10 年复发和 15 年乳腺癌死亡的影响：17 项随机试验中 10801 名女性患者个体数据的荟萃分析。
Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19.
5
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.术前化疗：国家外科辅助乳腺和肠道项目协议B - 18和B - 27的更新
J Clin Oncol. 2008 Feb 10;26(5):778-85. doi: 10.1200/JCO.2007.15.0235.
6
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.乳房切除术后放疗可改善对新辅助化疗取得病理完全缓解的局部晚期乳腺癌患者的预后。
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1004-9. doi: 10.1016/j.ijrobp.2007.01.023. Epub 2007 Apr 6.
7
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.如国际共识报告所建议的，乳房切除术后放疗的益处是否仅限于有四个或更多阳性淋巴结的患者？丹麦乳腺癌协作组82 b&c随机试验的亚组分析。
Radiother Oncol. 2007 Mar;82(3):247-53. doi: 10.1016/j.radonc.2007.02.001. Epub 2007 Feb 15.
8
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.早期乳腺癌放疗及手术范围差异对局部复发和15年生存率的影响：随机试验综述
Lancet. 2005 Dec 17;366(9503):2087-106. doi: 10.1016/S0140-6736(05)67887-7.
9
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.接受辅助化疗的高危乳腺癌患者的局部区域放射治疗：不列颠哥伦比亚省随机试验的20年结果。
J Natl Cancer Inst. 2005 Jan 19;97(2):116-26. doi: 10.1093/jnci/djh297.
Zotero 插件